The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia. (2013)

First Author: Spineli LM
Attributed to:  Evidence synthesis of clinical trials and human genome epidemiology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2013.03.006

PubMed Identifier: 23639793

Publication URI: http://europepmc.org/abstract/MED/23639793

Type: Journal Article/Review

Volume: 23

Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Issue: 9

ISSN: 0924-977X